REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 74 filers reported holding REVOLUTION MEDICINES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,049,286 | +23.6% | 3,325,480 | +19.5% | 0.46% | +19.1% |
| Q2 2023 | $74,458,090 | +4.7% | 2,783,480 | -15.2% | 0.39% | -1.5% |
| Q1 2023 | $71,122,776 | +75.8% | 3,283,600 | +93.4% | 0.39% | +63.1% |
| Q4 2022 | $40,446,717 | -18.0% | 1,698,015 | -32.1% | 0.24% | -11.7% |
| Q3 2022 | $49,300,000 | -22.2% | 2,500,000 | -23.1% | 0.27% | -21.1% |
| Q2 2022 | $63,343,000 | -23.6% | 3,250,000 | 0.0% | 0.35% | -13.5% |
| Q1 2022 | $82,908,000 | +19.8% | 3,250,000 | +18.2% | 0.40% | +15.6% |
| Q4 2021 | $69,218,000 | -8.5% | 2,750,000 | 0.0% | 0.35% | -2.0% |
| Q3 2021 | $75,653,000 | -4.7% | 2,750,000 | +10.0% | 0.35% | +9.0% |
| Q2 2021 | $79,350,000 | +7.4% | 2,500,000 | +55.3% | 0.32% | -11.7% |
| Q1 2021 | $73,854,000 | +16167.4% | 1,609,730 | +7664.1% | 0.37% | +9075.0% |
| Q1 2020 | $454,000 | – | 20,733 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |